Ophthalmic Viscoelastic Devices (OVD) Market Size, Share, Trends, Growth and Outlook 2025-2033

Market Overview

The global Ophthalmic Viscoelastic Devices (OVD) market size reached USD 2.8 Billion in 2024. The market is expected to grow to USD 3.8 Billion by 2033, with a CAGR of 3.34% during the forecast period 2025-2033. Growth is driven by the rising number of ophthalmic surgeries, extensive R&D activities, and expansion of the healthcare sector. These devices are essential in ophthalmic surgeries to protect ocular structures and facilitate safe procedures.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Ophthalmic Viscoelastic Devices (OVD) Market Key Takeaways

• The global Ophthalmic Viscoelastic Devices (OVD) market was valued at USD 2.8 Billion in 2024.
• The market is projected to grow at a CAGR of 3.34% during 2025-2033.
• The forecast period for this market study is 2025-2033.
• Cohesive ophthalmic viscoelastic holds the largest product share.
• Cataract surgery is the dominant application segment.
• Hospitals are the largest end users for OVDs.
• North America leads the market, driven by R&D, aging population, and diabetes-related ocular disorders.

Sample Request Link: https://www.imarcgroup.com/ophthalmic-viscoelastic-devices-market/requestsample

Market Growth Factors

Rising numbers of ophthalmic surgeries performed across the globe is a major growth driver for this market. OVDs are used extensively as they help maintain, preserve, displace, stabilize, and protect ocular tissues during such surgeries. In addition the increasing accessibility of ophthalmic care and awareness for ocular diseases is expected to increase market growth during the forecast period. Furthermore, the increasing usage of viscoadaptive OVDs due to the elimination of two syringes in complex ocular surgeries contributes to the growth of the market.

Viscoadaptive OVDs are used in complicated situations, such as pediatric cataract surgery, floppy iris syndrome, trauma cases, cases with Fuchs dystrophy, to prevent complications after intraocular surgery, and to improve surgical outcome. Considering their affordability and functionality, the combination package of cohesive and dispersive OVDs, which are packed in the same container, to be used simultaneously in surgery, has been widely used in routine cataract surgery by surgeons, considering the quality.

The ophthalmic viscoelastic devices market is expected to grow due to the increase in geriatric population and rise in the prevalence of diabetes and age-related eye disorders. In addition, the increase in the purchasing power of consumers, R&D, expanding healthcare industry, and government initiatives to reduce vision impairment will further help in the growth.

Market Segmentation

Product Insights:

• Cohesive Ophthalmic Viscoelastic: Holds the largest market share among OVD products due to its widespread use in ophthalmic surgeries.
• Dispersive Ophthalmic Viscoelastic: Also commonly used in surgical procedures but with a smaller share compared to cohesive OVD.

Application Insights:

• Cataract Surgery: The largest application segment, representing the majority use of ophthalmic viscoelastic devices.
• Glaucoma Surgery: A significant application where OVDs help protect ocular structures.
• Corneal Transplant: Utilizes OVDs to safeguard eye tissues during transplant surgery.
• Vitreoretinal Surgery: Deploys OVDs to maintain space and protect ocular tissues during the procedure.

End User Insights:

• Hospitals: Largest end user segment due to the high volume of ophthalmic procedures.
• Ophthalmic Clinics: Also significant users of OVDs in outpatient and specialized care settings.
• Others: Includes other healthcare providers using OVDs.

Regional Insights

North America dominates the ophthalmic viscoelastic devices market, supported by extensive R&D activities, a growing elderly population, and increasing prevalence of diabetes and age-related ocular disorders. This leadership position underlines the region's robust healthcare infrastructure and initiatives aimed at managing vision impairment.

Key Players

• Alcon Inc.
• Altacor Limited
• Bausch Health Companies Inc.
• Bohus Biotech Ab
• Carl Zeiss Meditec Ag
• Cima Technology Inc
• Eyekon Medical Inc.
• Johnson & Johnson
• RUMEX International Co.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=6898&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302